Global Outsourced Drug Discovery Market Research Report 2024
Published on: 2024-01-04 | No of Pages : 400 | Industry : Medical
Publisher : MRA | Format : PDF
Global Outsourced Drug Discovery Market Research Report 2024
In the fields of medicine, biotechnology and pharmacology, drug discovery is the process by which new candidate medications are discovered. Historically, drugs were discovered through identifying the active ingredient from traditional remedies or by serendipitousdiscovery.
According to MRAResearch’s new survey, global Outsourced Drug Discovery market is projected to reach US$ 34250 million in 2033, increasing from US$ 17840 million in 2022, with the CAGR of 11.1% during the period of 2023 to 2033. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Outsourced Drug Discovery market research.
The Drug Discovery Services market refers to the range of services provided by contract research organizations (CROs) and other service providers to support the drug discovery and development process. This market includes services such as target identification, lead optimization, preclinical testing, and clinical trial support. The Drug Discovery Services market has been experiencing significant growth due to factors such as the increasing complexity of drug development, rising outsourcing of research activities, and the need for specialized expertise. Key players in the market include CROs, pharmaceutical companies, and biotechnology firms. Geographically, the market is global, with regions witnessing a growing demand for outsourced drug discovery services.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2023-2033), aims to help readers to get a comprehensive understanding of global Outsourced Drug Discovery market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
IQVIA
Charles River Laboratories
Aptuit
Evotec
GenScript
PPD
WuXi AppTec
AMRI
Segment by Type
Chemical Services
Biological Services
Lead Optimization
Lead Identification and Screening
Pharmaceutical Companies
Other
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
The Outsourced Drug Discovery report covers below items
Chapter 1Product Basic Information (Definition, Type and Application)
Chapter 2Global market size, regional market size. Market Opportunities and Challenges
Chapter 3Companies’ Competition Patterns
Chapter 4Product Type Analysis
Chapter 5Product Application Analysis
Chapter 6 to 10Country Level Value Analysis
Chapter 11Companies' Outline
Chapter 12Market Conclusions
Chapter 13Research Methodology and Data Source
According to MRAResearch’s new survey, global Outsourced Drug Discovery market is projected to reach US$ 34250 million in 2033, increasing from US$ 17840 million in 2022, with the CAGR of 11.1% during the period of 2023 to 2033. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Outsourced Drug Discovery market research.
The Drug Discovery Services market refers to the range of services provided by contract research organizations (CROs) and other service providers to support the drug discovery and development process. This market includes services such as target identification, lead optimization, preclinical testing, and clinical trial support. The Drug Discovery Services market has been experiencing significant growth due to factors such as the increasing complexity of drug development, rising outsourcing of research activities, and the need for specialized expertise. Key players in the market include CROs, pharmaceutical companies, and biotechnology firms. Geographically, the market is global, with regions witnessing a growing demand for outsourced drug discovery services.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2023-2033), aims to help readers to get a comprehensive understanding of global Outsourced Drug Discovery market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
By Company
IQVIA
Charles River Laboratories
Aptuit
Evotec
GenScript
PPD
WuXi AppTec
AMRI
Segment by Type
Chemical Services
Biological Services
Lead Optimization
Lead Identification and Screening
Segment by Application
Pharmaceutical Companies
Other
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
The Outsourced Drug Discovery report covers below items
Chapter 1Product Basic Information (Definition, Type and Application)
Chapter 2Global market size, regional market size. Market Opportunities and Challenges
Chapter 3Companies’ Competition Patterns
Chapter 4Product Type Analysis
Chapter 5Product Application Analysis
Chapter 6 to 10Country Level Value Analysis
Chapter 11Companies' Outline
Chapter 12Market Conclusions
Chapter 13Research Methodology and Data Source